Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included Scott Gottlieb, MD, resigning as FDA commissioner; Eli Lilly offering a discounted version of Humalog; another study dispels the myths around autism and the measles, mumps, and rubella vaccine. Read more about the stories in this podcast: Dr Scott Gottlieb to Resign as FDA Commissioner: https://www.ajmc.com/newsroom/dr-scott-gottlieb-to-resign-as-fda-commissioner-reports-say Lilly to Launch Half-Price Version of Humalog: https://www.ajmc.com/newsroom/lilly-to-launch-halfprice-version-of-humalog What We're Reading: HIV Cured in Second Patient; Patients Question FDA; China Creating Ethics Committee: https://www.ajmc.com/newsroom/what-were-reading-hiv-cured-in-second-patient-patients-question-fda-china-creating-ethics-committee HIV Compendium: https://www.ajmc.com/compendium/hiv In Wake of Measles Ou

Realigning Accountability to Improve Population Healthcare Delivery Under MIPS by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included pharmaceutical executives appearing before a Senate drug pricing hearing; HHS finalizing a Title X rule change; and an analysis that found travel and wait times for healthcare services come with a high price. Read more about the stories in this podcast: Senate Committee Discusses the Burden of High Drug Prices and Potential Solutions: https://www.ajmc.com/newsroom/senate-committee-discusses-the-burden-of-high-drug-prices-and-potential-solutions Pharma Executives Call for Reforms to Medicare, Rebate System in Senate Hearing: https://www.ajmc.com/focus-of-the-week/pharma-executives-call-on-reforms-to-medicare-rebate-system-in-senate-hearing HHS Rule Bars Clinics That Perform Abortion, Make Referrals From Receiving Title X Funds: https://www.ajmc.com/newsroom/hhs-rule-bars-clinics-that-perform-aborti

Improving Oncology Practices With Value Based Care by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included CMS' proposal to cover chimeric antigen receptor T-cell therapy; a study faulting the FDA’s handling of fentanyl oversight; and breast surgeons calling for genetic testing for all patients with breast cancer. Read more about the stories in this podcast: CMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy: https://www.ajmc.com/newsroom/cms-proposes-that-patients-be-enrolled-in-studies-to-get-coverage-for-car-tcell-therapy Study Criticizes FDA Safety Oversight of Rapid-Release Fentanyl: https://www.ajmc.com/newsroom/study-criticizes-fda-safety-oversight-of-rapidrelease-fentanyl Breast Surgeons Seek Genetic Testing for All Patients With Breast Cancer: https://www.ajmc.com/newsroom/breast-surgeons-seek-genetic-testing-for-all-patients-with-breast-cancer Greater Die

Improving Care While Reducing Costs Through ACOs and Other Value-Based Efforts by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included increased demand for long-acting contraception since President Trump took office; a payer decision on an insulin pump alarmed diabetes advocates; and despite being involved in cancer treatment decisions, many primary care providers don't feel prepared to do so. Read more about the stories in this podcast: Demand for Long-Acting Contraception Increased in Wake of Concerns About Birth Control Access: https://www.ajmc.com/focus-of-the-week/demand-for-longacting-contraception-increased-in-wake-of-concerns-about-birth-control-access JDRF Alarmed by Extension of UnitedHealthcare-Medtronic Pact to Youth With Type 1 Diabetes: https://www.ajmc.com/focus-of-the-week/jdrf-alarmed-by-extension-of-unitedhealthcaremedtronic-pact-to-youth-with-type1diabetes Despite Being Involved in Cancer Treatment Decisions, P

Does Providing Women With Cesarean Delivery Rate Comparison Data Influence Hospital Choice? by Managed Care Cast

Understanding the Scope and Drivers of the Opioid Epidemic by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included President Trump's State of the Union address highlighting healthcare; HHS Secretary Alex Azar taking on drug rebates; physicians asking Congress to fully implement the HITECH Act. Read more about the stories in this podcast: Trump Highlights New Initiatives for Childhood Cancer, HIV in State of the Union: https://www.ajmc.com/newsroom/trump-highlights-new-initiatives-for-childhood-cancer-hiv-in-state-of-the-union Azar Promotes Efforts to Tackle Rebate System: https://www.ajmc.com/conferences/academyhealth-2019/azar-promotes-efforts-to-tackle-rebate-system AcademyHealth 2019 National Health Policy Conference: https://www.ajmc.com/conferences/academyhealth-2019 Campaign Seeks Push to Improve Usability of EHRs: https://www.ajmc.com/focus-of-the-week/campaign-seeks-push-to-improve-usability-of-ehrs Ge

Overheard at AcademyHealth: Health Policy, Social Determinants, and Data by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included House and Senate hearings on the cost of prescription drugs; a study finding patients with diabetes can be safely switched to cheaper insulin; and the first non-chemotherapy combination being approved for the treatment of chronic lymphocytic leukemia. Read more about the stories in this podcast: Senate Committee Discusses the Burden of High Drug Prices and Potential Solutions: https://www.ajmc.com/newsroom/senate-committee-discusses-the-burden-of-high-drug-prices-and-potential-solutions Medicare Patients With Type 2 Diabetes Safely Switched From Analog to Human Insulin, JAMA Study Finds: https://www.ajmc.com/newsroom/medicare-patients-with-type-2-diabetes-safely-switched-from-analog-to-human-insulin-ijamai-study-finds FDA Approves Ibrutinib Combination as Frontline Treatment for CLL: https://www.a

Discussing the Continuing Decline in Overall Cancer Mortality in the United States by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. ​​​​​​​This week, the top managed care news included the Institute for Clinical and Economic Review investigating rising drug prices; CMS expanding value-based insurance design; and researchers using a blood test to detect preclinical Alzheimer disease. Read more about the stories in this podcast: What's Driving US Healthcare Costs? Stakeholders Weigh In: https://www.ajmc.com/focus-of-the-week/whats-driving-us-healthcare-costs-stakeholders-weigh-in ICER Will Review If Drug Price Hikes Are Supported by New Evidence: https://www.ajmc.com/newsroom/icer-will-review-if-drug-price-hikes-are-supported-by-new-evidence Report: Increasing Drug Prices, Shortages Causing Hospitals to Cut Staff, Putting Patient Safety at Risk: https://www.ajmc.com/focus-of-the-week/report-increasing-drug-prices-shortages-causing-hospitals-to-cut-staff-putting-patient-safe

As Cancer Incidence Changes, so Do Screening Recommendations by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included a new investigation into drug prices; FDA Commissioner Scott Gottlieb, MD, provided updates on how the government shutdown is impacting FDA work; research found comorbidities impede clinical trial participation for patients with cancer. Read more about the stories in this podcast: Biologics, Diabetes, Cancer Drugs on House Oversight Probe List: https://www.ajmc.com/newsroom/biologics-diabetes-cancer-drugs-on-house-oversight-probe-list HHS Medicare Drug Shift Plan Could Reduce Costs Overall but Raise Them for Some, Researchers Say: https://www.ajmc.com/newsroom/hhs-medicare-drug-shift-plan-could-reduce-costs-overall-but-raise-them-for-some-researchers-say What We're Reading: FDA Resumes Some Inspections; Walmart Leaves CVS' PBM Networks; Flu Season: https://www.ajmc.com/newsroom/what-were-reading-f

Understanding What Drives Health Information Exchange Use During Postacute Care Transitions by Managed Care Cast

Two Years Into OCM: Successes, Challenges, and Lessons Learned by Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included the FDA commissioner discussing boosting drug competition; BMS offering details on its acquisition of Celgene; and cancer mortality rates declining for the 25th consecutive year. Read more about the stories in this podcast: FDA's Scott Gottlieb, MD, Highlights Biosimilars Initiatives in J.P. Morgan Keynote Address: https://www.centerforbiosimilars.com/conferences/jp-morgan-2019/fdas-scott-gottlieb-md-highlights-biosimilars-initiatives-in-jp-morgan-keynote-address BMS, Celgene Discuss $74 Billion Acquisition During JP Morgan Healthcare Conference: https://www.ajmc.com/newsroom/bms-celgene-discuss-74-billion-acquisition-during-jp-morgan-healthcare-conference Cancer Mortality Rate Drops for the 25th Consecutive Year, but Socioeconomic Gap Widens: https://www.ajmc.com/focus-of-the-week/cancer-mortalit

Last year was a big year for biosimilars in the United States with the number of FDA-approved biosimilars nearly doubling and major policy and regulatory developments taking place in 2018. Kelly Davio, senior editor of AJMC's The Center for Biosimilars, highlights recent progress, how the US market compares with Europe, and what remains to be seen. Read more: The Center for Biosimilars: https://www.centerforbiosimilars.com/ Stakeholders Weigh In on the Key Biosimilar Developments of 2018: https://www.centerforbiosimilars.com/news/stakeholders-weigh-in-on-the-key-biosimilar-developments-of-2018 Coherus Confirms That It Has Launched Its Pegfilgrastim Biosimilar, Udenyca: https://www.centerforbiosimilars.com/news/coherus-confirms-that-it-has-launched-its-pegfilgrastim-biosimilar-udenyca FDA Releases Biosimilar Action Plan: https://www.centerforbiosimilars.com/news/fda-releases-biosimilar-action-plan Pfizer Launches Epoetin Alfa Biosimilar, Retacrit, at 33.5% Discount to Reference Epogen: https://www.centerforb